stars 1 stars 2 stars 3

ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you. We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor. Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide. Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS: 👉a new group of investors that will sustain the completion of OUR PROJECT 👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision. *May 28, 2014 http://doi.org/10.1093/brain/awu102.

View Top Employees from Aleva Neurotherapeutics SA
Website http://www.aleva-neuro.com
Revenue $6 million
Funding $39 million
Employees 20 (20 on RocketReach)
Founded 2013
Address EPFL Innovation Park, Building D, Lausanne, Vaud 1015, CH
Phone +41 21 624 71 10
Technologies
Industry Retail, Medical Equipment Manufacturing, Health Diagnostics, Neurosurgery, Health Care, Deep Brain Stimulation, Medical Device, Medical Device Development, Neuroscience, Biotechnology, Science and Engineering
Web Rank 30 Million
Competitors Acadia Pharmaceuticals Inc., Acera Surgical, Arkis BioSciences, Brainstorm Cell Therapeutics, Novus Scientific
SIC SIC Code 38 Companies, SIC Code 384 Companies
NAICS NAICS Code 33 Companies, NAICS Code 334 Companies

Aleva Neurotherapeutics SA Questions

The Aleva Neurotherapeutics SA annual revenue was $6 million in 2024.

André Mercanzini is the Founder of Aleva Neurotherapeutics SA.

20 people are employed at Aleva Neurotherapeutics SA.

Aleva Neurotherapeutics SA is based in Lausanne, Vaud.

The NAICS codes for Aleva Neurotherapeutics SA are [33, 334].

The SIC codes for Aleva Neurotherapeutics SA are [38, 384].

Top Aleva Neurotherapeutics SA Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users